Rapid Diagnostic Supporting Antimicrobial Stewardship in Patients With Pneumonia

FDA-approved/cleared molecular, multiplex device that rapidly identifies viruses, bacteria, and antimicrobial resistance genes in sputum-like and bronchoalveolar lavage (BAL)-like specimens obtained from individuals with signs of a lower respiratory tract infection.

Standard of care Gram stain, culture and other clinically ordered tests will be performed per standard practice.